Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
22 July 2020 | Story Nonsindiso Qwabe | Photo Supplied
Tau Tladi.

In times of great difficulty, a tale of hope goes a long way in encouraging one to persevere. Tau Tladi, a second-year LLB extended-programme student who was diagnosed with ataxia – a degenerative disease of the nervous system – at a young age, has conquered many adversities. He is living his life to the fullest, pursuing his dream of becoming a lawyer one day. Because of a brain injury during birth, Tladi struggles to speak, write, or walk. On campus, he makes use of a scribe and reader to write his tests and exams. 

Learning from others key to success

“Living with ataxia means I have improper speech, I struggle to walk properly, my hands can’t grab things properly, and I can’t even write with them.   Seeing other people living with disabilities and still pursuing their dreams has inspired me a lot; it made me realise that I too have the ability to achieve my dreams,” he said. 
While this disability presented him with many hindrances in life, it has never held him back. “Growing up was challenging because I was not able to develop like other children. As I got older, I could not experience some of the things that other kids could do, such as playing and running around,” he said.

Triumph in the face of adversity
 
Despite all the challenges, Tau completed his matric in 2016 and was even named as one of the top 100 achievers in the Free State. He describes his admission to the LLB programme as a dream come true. “I have always wanted to study an LLB degree. It is the best feeling ever to be at university and studying something that I always wanted to do. I would love to become an attorney.”

Tladi hopes to finish his degree in 2021. He is also an avid sportsman, having participated in the Free State paracycling team and winning first place at the national competition. 

“Living with disability has never been easy for me, so I have learned to be grateful and use every opportunity that I come across and work very hard to fulfil my dreams.”

Hanlie Grobler, Senior Officer in the Faculty of Law, described Tladi as a remarkable young man who always wears a smile on his face. “If you are feeling a bit blue today, cheated by COVID-19, that life is unfair to you – remember this young man who is an excellent example of determination, and do what you have to do, to the best of your ability, and be thankful for what you have.”

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk. Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept